Year | Detail |
1967 |
Dr. Habil Khorakiwala founded Wockhardt, a research-based global healthcare company. |
1972 |
Wockhardt launched PROXYVON, the first combination formulation in pain management for the healthcare industry. |
2003 |
The company acquired CP Pharmaceuticals for $15.5 million, which will grow the Indian company's UK market presence and develop a larger manufacturing base, allowing it to expand its business into other European markets. |
2006 |
Wockhardt acquired Pinewood Laboratories Ltd. for around $150 million. This acquisition will give Wockhardt a larger footprint in Europe, which includes the UK, Ireland, and Germany. |
2020 |
The UK government partnered with Wockhardt to provide fill and finish services as part of an effort to accelerate vaccine manufacturing in the UK. |
2021 |
Wockhardt partnered with Jemincare for Wockhardt's novel patented antibiotic WCK 4873 in the People's Republic of China, Hong Kong, Macau, and Taiwan to treat community-acquired bacterial pneumonia and other respiratory tract infections. |
2022 |
Wockhardt & Serum Life Sciences UK collaborated to manufacture multiple vaccines in the UK. |